🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to transition patients who have been stable on...
Status
Completed
Location
Emory Clinic
Start Date
2015-09
Trial ID
NCT02560558
Treatments Being Tested
The purpose of this study is to estimate overall survival (OS) for particip...
Status
Completed
Location
Local Institution
Start Date
2019-09-16
Trial ID
NCT05421299
The purpose of this study is to describe infliximab and abatacept dosing pa...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01141413
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
This is a phase 2a, multi-center, randomized and double-blind placebo-contr...
Status
Completed
Location
CHU Sainte-Justine
Start Date
2022-03-01
Trial ID
NCT04872218
Treatments Being Tested
The purpose of this protocol is to determine the single-dose pharmacokineti...
Status
Completed
Location
California Clinical Trials Medical Group
Start Date
1995-11
Trial ID
NCT00277225
Treatments Being Tested
This study will determine the incidences of infections and malignancies amo...
Status
Completed
Location
Local Institution
Start Date
2016-07-12
Trial ID
NCT03769558
Treatments Being Tested
Belatacept is an experimental medication shown in clinical trials to have i...
Status
Terminated
Location
University of California, San Francisco
Start Date
2006-12
Trial ID
NCT00346151
Treatments Being Tested
* To determine the utility of novel blood-based immune monitoring tools (Al...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-02-11
Trial ID
NCT04177095
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested